Emergent BioSolutions Awarded $379.6M Procurement Contract To Supply RSDL To U.S. Department Of Defense
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an indefinite-delivery, indefinite-quantity procurement contract with a maximum value up to $379.6 million to supply
Chase Q1 Adj. EPS $1.00 Down From $1.07 YoY, Sales $102.89M Up From $75.01M YoY
Chase (AMEX:CCF) reported quarterly earnings of $1.00 per share. This is a 6.54 percent decrease over earnings of $1.07 per share from the same period last year. The company reported $102.89 million in sales this